1.A Case of Spontaneously Remitted Congenital Minimal Change Nephrotic Syndrome.
Tae Sun HA ; Kyung Hee LEE ; Baek Soo PARK ; Heon Seok HAN
Journal of the Korean Pediatric Society 1995;38(9):1288-1292
No abstract available.
Nephrosis, Lipoid*
3.Minimal change disease associated with SARS-CoV-2 (COVID-19) infection among adult Filipinos: A report of two cases and review of related literature
Renz Michael F. Pasilan ; Sheryll Anne R. Manalil ; Anthony Russell T. Villanueva
Acta Medica Philippina 2024;58(5):62-67
A 40-year-old Filipino female with a history of right total mastectomy for a low-grade phyllodes tumor was admitted due to stillbirth. Her laboratory results revealed an incidental finding of a positive COVID-19 RT-PCR swab, serum creatinine 1.04 mg/dL, urine RBC 1/HPF, and a 24-hour urine protein of 9.22 grams with hypoalbuminemia and dyslipidemia. Serologic workup was noted to be negative. A kidney biopsy was performed which demonstrated unremarkable light microscopy (LM) and immunofluorescence (IF) with widespread podocyte-foot process effacement, consistent with minimal change disease. She was started on prednisone (1 mg/kg/day) and achieved complete remission after six weeks. A 61-year-old Filipino male with a history of Type 2 Diabetes Mellitus, Hypertension, Dyslipidemia, and mild COVID-19 infection four months prior, now presented with diarrhea. On admission, his COVID-19 RT-PCR swab revealed a reinfection. Workup demonstrated a serum creatinine 3.39 mg/dL, urine RBC 2/HPF, and urine ACR 2.6 g/g. Serologic tests were negative. He was diagnosed with Nephrotic Syndrome and underwent kidney biopsy. Findings showed an unremarkable LM and IF with widespread podocyte-foot process effacement, consistent with minimal change disease. He was started on prednisone (1 mg/kg/day) and achieved complete remission after eight weeks. SARS-CoV-2 (COVID-19) may present with a variety of kidney involvement which includes glomerulopathies such as MCD. An accurate diagnosis using the patient’s clinical presentation, renal histopathology, and adjunct laboratory examinations, is essential to direct effective management and good outcomes.
COVID-19
;
Nephrosis, Lipoid
;
Nephrotic Syndrome
4.Lipoprotein Profiles in Minimal Change Nephrotic Syndrome.
Yong CHOI ; Heui Jeen KIM ; Hae Il CHEONG ; Jeong Kee SEO ; Kwang Wook KO
Journal of the Korean Pediatric Society 1983;26(3):237-246
No abstract available.
Lipoproteins*
;
Nephrosis, Lipoid*
5.The use of tacrolimus in the management of minimal change disease.
Kidney Research and Clinical Practice 2012;31(4):257-258
No abstract available.
Nephrosis, Lipoid
;
Tacrolimus
6.Selectivity Index of Proteinuria in Childhood Minimal Change Nephrotic Syndrome.
Cheol Ho LEE ; Young Seo PARK ; Kwang Wook KO
Journal of the Korean Pediatric Society 1989;32(10):1384-1390
No abstract available.
Nephrosis, Lipoid*
;
Proteinuria*
7.A Study on Minimal Change Nephrotic Syndrome in Children.
Yong CHOI ; Hong Jin LEE ; Hae Il CHEONG ; Kwang Wook KO ; Hyun Soon LEE ; Yong Il KIM
Journal of the Korean Pediatric Society 1988;31(2):220-226
No abstract available.
Child*
;
Humans
;
Nephrosis, Lipoid*
8.Minimal Change Disease Associated with Ingestion of Poison Sumac.
Jong Hwan JUNG ; Seon Ho AHN ; Ju Hung SONG
Chonnam Medical Journal 2018;54(3):201-202
No abstract available.
Eating*
;
Nephrosis, Lipoid*
;
Toxicodendron*
9.A Case of Levamisole Treatment for Kimura's Disease-Associated Nephrotic Syndrome.
Jaesung YU ; Hyunju JIN ; Hoseok KANG
Korean Journal of Nephrology 2011;30(3):315-320
Kimura's disease is a chronic inflammatory soft tissue disorder with peripheral eosinophila and high serum IgE. It might be associated with nephrotic syndrome. We report a 6-year-old boy with Kimura's disease and the concurrent steroid dependant minimal change nephrotic syndrome. With levamisole treatment fot 24 months, tumor progression and relapse of the associated nephrotic syndrome were not observed.
Child
;
Humans
;
Immunoglobulin E
;
Levamisole
;
Nephrosis, Lipoid
;
Nephrotic Syndrome
;
Recurrence
10.Cyclosporin A in the child minimal change nephrotic syndrome.
Pyung Kil KIM ; Soo Kyung YUN ; Ki Soo PAI ; Ja HOon KOO ; Cheul Woo KOH
Korean Journal of Nephrology 1993;12(4):549-556
No abstract available.
Child*
;
Cyclosporine*
;
Humans
;
Nephrosis, Lipoid*